Developing and selling bioprinter devices that can be used by hospitals, research institutes, and other organizations seeking to print biological substitutes and materials.

Companies that use propietary or third-party printers to produce and sell bioprinted tissues, including impants, organ replacement, and other types of tissues.

Companies that are developing materials and bioinks, that can be used in bioprinting devices. This includes material technologies and nanofibers.

Developing software solutions and applications for designing and managing the bioprinting production process.

Enabling supply of biologically safe tissues and organs using next-gen printing tech

Bioprinting

Overview

<div>
  <p>
    Bioprinting is the process of using cells and biological material (called bioinks) for 3D printing structures that allow living cells to multiply and grow. The technology can be applied across multiple uses, including organ replacement, cosmetic surgery, and drug development.&nbsp;
  </p>
  <p>
    Advances in 3D printing technology have made bioprinting devices commercially viable. Bioprinting can be done using a range of methods, including magnetic levitation as well as inkjet-based, syringe-based, and laser-based printing. Going forward, its development will be focused on bioprinting devices and bioink materials, as having viable materials that can be safely implanted and used in the human body is key to the success of the industry. From a demand perspective, one of the primary drivers is the shrinking number of organ donors, along with population growth and the prevalence of chronic conditions that could be treated through organ and tissue replacement.&nbsp;
  </p>
  <p>
    Note: Additional sections (such as market sizing, detailed overview, and incumbents) can be provided on request.
  </p>
</div>


Bioprinting

Bioprinting

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless